197 related articles for article (PubMed ID: 22495041)
1. [Clinical effectiveness of measurement of serum total human chorionic gonadotropin for diagnosis and management of testicular seminomatous germ cell tumor].
Takizawa A; Kishida T; Miura T; Ishida H; Noguchi K; Hattori Y; Kubota Y
Hinyokika Kiyo; 2012 Mar; 58(3):137-42. PubMed ID: 22495041
[TBL] [Abstract][Full Text] [Related]
2. [false-positive results of human chorionic gonadotropin β measurement after high orchiectomy for stage i seminoma: report of a case].
Tomita K; Nishikawa N; Takimoto K; Kim CJ
Hinyokika Kiyo; 2010 Nov; 56(11):663-5. PubMed ID: 21187715
[TBL] [Abstract][Full Text] [Related]
3. False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancer.
Trojan A; Joller-Jemelka H; Stahel RA; Jacky E; Hersberger M
Oncology; 2004; 66(4):336-8. PubMed ID: 15218303
[TBL] [Abstract][Full Text] [Related]
4. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients.
Hoshi S; Suzuki K; Ishidoya S; Ohyama C; Sato M; Namima T; Saito S; Orikasa S
Int J Urol; 2000 Jun; 7(6):218-23. PubMed ID: 10843453
[TBL] [Abstract][Full Text] [Related]
5. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
6. [Significance of thcg assay in the management of testicular cancer--the possibility of a standard assay in testicular cancer as an alternative to FbetahCG assay].
Takizawa A; Miura T; Kishida T; Fujinami K; Osada Y; Hattori Y; Saito K; Noguchi K; Kubota Y
Nihon Hinyokika Gakkai Zasshi; 2007 Jan; 98(1):23-9. PubMed ID: 17302291
[TBL] [Abstract][Full Text] [Related]
7. Choriogonadotropin positive seminoma-a clinicopathological and molecular genetic study of 15 cases.
Hes O; Pivovarcikova K; Stehlik J; Martinek P; Vanecek T; Bauleth K; Dolejsova O; Petersson F; Hora M; Perez Montiel D; Peckova K; Branzovsky J; Slouka D; Vodicka J; Kokoskova B; Matej R; Michal M
Ann Diagn Pathol; 2014 Apr; 18(2):89-94. PubMed ID: 24480432
[TBL] [Abstract][Full Text] [Related]
8. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
Mumperow E; Kressel K; Hartmann M
Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of low level human chorionic gonadotropin in the management of testicular germ cell tumor.
Takizawa A; Kishida T; Miura T; Hattori Y; Noguchi K; Kubota Y
J Urol; 2008 Mar; 179(3):930-4; discussion 934-5. PubMed ID: 18207192
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in testicular cancer].
Mann K
Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
[TBL] [Abstract][Full Text] [Related]
11. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.
Ferraro S; Trevisiol C; Gion M; Panteghini M
Clin Chem; 2018 Feb; 64(2):270-278. PubMed ID: 29021329
[TBL] [Abstract][Full Text] [Related]
12. Role of human chorionic gonadotropin in patients with pure seminoma.
Rüther U; Rothe B; Grunert K; Bader H; Sessler R; Nunnensiek C; Rassweiler J; Lüthgens M; Eisenberger F; Jipp P
Eur Urol; 1994; 26(2):129-33. PubMed ID: 7525293
[TBL] [Abstract][Full Text] [Related]
13. Utility of serum tumor markers during surveillance for stage I seminoma.
Vesprini D; Chung P; Tolan S; Gospodarowicz M; Jewett M; O'Malley M; Sweet J; Moore M; Panzarella T; Sturgeon J; Sugar L; Anson-Cartwright L; Warde P
Cancer; 2012 Nov; 118(21):5245-50. PubMed ID: 22517478
[TBL] [Abstract][Full Text] [Related]
14. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
15. Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?
Suzuki K; Nakazato H; Kurokawa K; Suzuki T; Suzuki K; Yamanaka H
Int Urol Nephrol; 1998; 30(5):593-8. PubMed ID: 9934803
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
17. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
[TBL] [Abstract][Full Text] [Related]
18. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
[TBL] [Abstract][Full Text] [Related]
19. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
Bruns F; Raub M; Schaefer U; Micke O
Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
[TBL] [Abstract][Full Text] [Related]
20. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]